The androgen-signaling pathway is important for the growth and progression of prostate cancer. Androgen ablation therapy, which may result in programmed cell death, is often used to treat advanced prostate cancer. The growth-promoting effects of androgen are mediated mostly through the androgen morphogenic proteins (BMPs), play critical roles in controlling prostate cell proliferation, differentiation, and apoptosis. The TGF-beta pathway is often inactivated by loss of normal transcripts and proteins of TGF-beta receptors in prostate cancer cells, especially in advanced stages of the disease. Since androgen promotes the growth and proliferation of prostatic epithelial cells and TGF-beta negatively regulates this process, a potential crosstalk between TGF-beta and androgen pathways has been proposed. However, to date there has been no data showing a direct link between these two important pathways, Recently, we demonstrated for the first time that Smad 3, a nuclear transducer of TGF-beta, specifically repressed transcriptional activation mediated by AR. This repression is transmitted directly through TGF- beta signaling and can be regulated by other Smad proteins. A protein- protein interaction between AR and Smad3 was identified both in vitro and in vivo. These results suggest that TGF-beta suppression of prostate cancer cell growth may be mediated through interaction with the androgen signaling pathway, and that the interaction between AR and Smad3 may be a convergent point between these two pathways. It is also possible that loss of TGF-beta signaling during the progression to androgen-independent disease may augment AR activity in the setting of decreased androgen. Our major objective in this proposal is to study the interaction between AR and Smad3 in order to understand the crosstalk between androgen and TGF-beta pathways in prostate cancer development and progression. Ultimately, we wish to determine the biological roles of Smad3 in cooperatively regulating AR functions (Aims 1 and 2) to determine whether expression of Smad3 is altered during prostate cancer progression (Aim 3). The long-term goal of this study is to identify new steps that can be targeted in the treatment of prostate cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Sathyamoorthy, Neeraja
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
Schools of Medicine
United States
Zip Code
Peng, Yue; Lee, Jane; Zhu, Chunfang et al. (2010) A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription. J Biol Chem 285:11465-75
Beliakoff, Jason; Lee, Jane; Ueno, Hiroo et al. (2008) The PIAS-like protein Zimp10 is essential for embryonic viability and proper vascular development. Mol Cell Biol 28:282-92
Lee, Jane; Beliakoff, Jason; Sun, Zijie (2007) The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor. Nucleic Acids Res 35:4523-34
Li, Tzu-Huey; Zhao, Hongjuan; Peng, Yue et al. (2007) A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells. Nucleic Acids Res 35:2767-76
Verras, Meletios; Lee, Jane; Xue, Hui et al. (2007) The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression. Cancer Res 67:967-75
Li, Xiaomeng; Thyssen, Gregory; Beliakoff, Jason et al. (2006) The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity. J Biol Chem 281:23748-56
Verras, Meletios; Sun, Zijie (2006) Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett 237:22-32
Thyssen, Gregory; Li, Tzu-Huey; Lehmann, Lynn et al. (2006) LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin. Mol Cell Biol 26:8857-67
Verras, Meletios; Sun, Zijie (2005) Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor. Mol Endocrinol 19:391-8
Huang, Chun-Yin; Beliakoff, Jason; Li, Xiaoyu et al. (2005) hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes. Mol Endocrinol 19:2915-29

Showing the most recent 10 out of 13 publications